اخبار و اعلانات

 آمار

تعداد نشریات286
تعداد نشریات سازمان84
تعداد شماره‌ها2,846
تعداد مقالات32,300
تعداد مشاهده مقاله41,387,128
تعداد دریافت فایل اصل مقاله18,562,183
Abdalsatar Abdalrazaq, N, Ezleen Binti Kamarulzaman, E. (1401). Design, Synthesis, and in-vitro Protease Inhibition Assay of Linear Pentapeptides as Potential Dengue Virus NS2B/NS3 Protease Inhibitors. سامانه مدیریت نشریات علمی, 77(2), 843-852. doi: 10.22092/ari.2022.357124.1980
N Abdalsatar Abdalrazaq; E Ezleen Binti Kamarulzaman. "Design, Synthesis, and in-vitro Protease Inhibition Assay of Linear Pentapeptides as Potential Dengue Virus NS2B/NS3 Protease Inhibitors". سامانه مدیریت نشریات علمی, 77, 2, 1401, 843-852. doi: 10.22092/ari.2022.357124.1980
Abdalsatar Abdalrazaq, N, Ezleen Binti Kamarulzaman, E. (1401). 'Design, Synthesis, and in-vitro Protease Inhibition Assay of Linear Pentapeptides as Potential Dengue Virus NS2B/NS3 Protease Inhibitors', سامانه مدیریت نشریات علمی, 77(2), pp. 843-852. doi: 10.22092/ari.2022.357124.1980
Abdalsatar Abdalrazaq, N, Ezleen Binti Kamarulzaman, E. Design, Synthesis, and in-vitro Protease Inhibition Assay of Linear Pentapeptides as Potential Dengue Virus NS2B/NS3 Protease Inhibitors. سامانه مدیریت نشریات علمی, 1401; 77(2): 843-852. doi: 10.22092/ari.2022.357124.1980

Design, Synthesis, and in-vitro Protease Inhibition Assay of Linear Pentapeptides as Potential Dengue Virus NS2B/NS3 Protease Inhibitors

Archives of Razi Institute
مقاله 42، دوره 77، شماره 2، خرداد و تیر 2022، صفحه 843-852    اصل مقاله (603.75 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2022.357124.1980
نویسندگان
N Abdalsatar Abdalrazaq* 1، 2؛ E Ezleen Binti Kamarulzaman* 1
1Discipline of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, University of Science, Malaysia (USM), 11800, Penang, Malaysia
2College of Pharmacy, University of Uruk, Baghdad, Iraq
چکیده
Nowadays dengue virus infection (DENV) is one of the major health complications in the world. Although DENV is an old and common disease, unfortunately, until now, there are no specific relevant treatments available for it. This study, therefore, aimed to design, as well as synthesize selective peptide inhibitors, and investigate their activity by in-vitro NS2B/NS3 protease inhibition assay. The design of the peptide ligands was based on studying the interactions with the dengue NS2B/NS3 protease using the computational docking technique in the MOE and AutoDock (version 4.2) software. To this end, the researchers designed 26 linear pentapeptides based on previous studies. It was revealed that two linear pentapeptides (i.e., GKRRK and KRRRK) are the best potential inhibitors. Furthermore, based on the findings of the two independent docking programs, the peptide GKRRK was synthesized by solid-phase peptide synthesis and its structure was confirmed. The in-vitro protease inhibitor study was conducted for these two peptides to examine their activity against the dengue virus using a protin in as a control. It was found that the designed potential peptides possess interesting inhibition against the NS2B/NS3 protease. Additionally, the findings showed that the peptide GKRRK had the highest percentage of inhibition (71.11%) at 100 µM with the IC50of48.87 µM; therefore, this linear peptide could serve as a good inhibitor for the DENV.
کلیدواژه‌ها
Dengue virus؛ in-vitro protease assay؛ Linear pentapeptides؛ Molecular docking؛ NS2B/NS3 protease
سایر فایل های مرتبط با مقاله
مراجع
  1. Bhatt S, Gething, PW, Brady, OJ, Messina, JP, Farlow, AW, Moyes, CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504-7.
  2. Mercorelli B, Palù G, Loregian A. Drug repurposing for viral infectious diseases: how far are we? Trends Microbiol. 2018;26(10):865-76.
  3. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002;108(5):717-25.
  4. Lindenbach BD, Rice CM. Molecular biology of flaviviruses. Adv Virus Res. 2003;59:23-62.
  5. Boas LCPV, Campos ML, Berlanda RLA, de Carvalho Neves N, Franco OL. Antiviral peptides as promising therapeutic drugs. Cell Mol Life Sci. 2019:1-18.
  6. Ismail NA, Jusoh SA. Molecular docking and molecular dynamics simulation studies to predict flavonoid binding on the surface of DENV2 E protein. Interdiscip Sci. 2017;9(4):499-511.
  7. Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, et al. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res. 2008;80(2):94-101.
  8. Yin Z, Patel SJ, Wang W-L, Chan W-L, Rao KR, Wang G, et al. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg Med Chem Lett. 2006;16(1):40-3.
  1. Wichapong K, Pianwanit S, Sippl W, Kokpol S. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction. J Mol Recognit. 2010;23(3):283-300.
  2. Idrees S, Ashfaq UA. Discovery and design of cyclic peptides as dengue virus inhibitors through structure-based molecular docking. Asian Pac J Trop Med. 2014;7(7):513-6.
  3. Nadeem Abdalsatar Abdalrazaq EEK. Rational design of cyclic tetra and pentapeptides as therapeutic agents for dengue NS2B/NS3 protease using structure-based molecular docking (MOE and AutoDock 4.2). Int J Pharm Sci Rev Res. 2020;11(4):5501-10.
  4. Tambunan USF, Alamudi S. Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach. Bioinformation. 2010;5(6):250.
  5. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng Des Sel. 1995;8(2):127-34.
  6. Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc. 1963;85(14):2149-54.
  7. Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, et al. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol. 2006;13(4):372.
  1. Aziz NBA. Recominant NS3 serin protease from dengue virus 2 as a screen for small molecules University Sains Malaysia; 2011.
  2. Kiat TS, Pippen R, Yusof R, Ibrahim H, Khalid N, Abd Rahman N. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett. 2006;16(12):3337-40.
  3. Tomlinson SM, Malmstrom RD, Russo A, Mueller N, Pang Y-P, Watowich SJ. Structure-based discovery of dengue virus protease inhibitors. Antiviral Res. 2009;82(3):110-4.
  4. Kapetanovic I. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem Biol Interact. 2008;171(2):165-76.
  5. Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ. Virtual screening with AutoDock: theory and practice. Expert Opin Drug Discov. 2010;5(6):597-607.
  6. van Hell AJ, Crommelin DJ, Hennink WE, Mastrobattista E. Stabilization of peptide vesicles by introducing inter-peptide disulfide bonds. Pharm Res. 2009;26(9):2186-93.
  7. Arunan E, Desiraju GR, Klein RA, Sadlej J, Scheiner S, Alkorta I, et al. Definition of the hydrogen bond (IUPAC Recommendations 2011). Pure Appl Chem. 2011;83(8):1637-41.
  8. Chan W, White P. Fmoc solid phase peptide synthesis: a practical approach: OUP Oxford; 1999.
  9. Lin K-H, Ali A, Rusere L, Soumana DI, Yilmaz NK, Schiffer CA. Dengue virus NS2B/NS3 protease inhibitors exploiting the prime side. J Virol. 2017;91(10).
آمار
تعداد مشاهده مقاله: 1,436
تعداد دریافت فایل اصل مقاله: 426


counter
سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب